Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M331,089Revenue (TTM) $M71,890Net Margin (%)22.8Altman Z-Score--
Enterprise Value $M331,089EPS (TTM) $5.9Operating Margin %29.4Piotroski F-Score--
P/E(ttm)20.8Beneish M-Score--Pre-tax Margin (%)27.5Higher ROA y-yN
Price/Book4.610-y EBITDA Growth Rate %1.2Quick Ratio--Cash flow > EarningsN
Price/Sales4.75-y EBITDA Growth Rate %9.4Current Ratio--Lower Leverage y-yN
Price/Free Cash Flow34.6y-y EBITDA Growth Rate %-7.1ROA % (ttm)12.1Higher Current Ratio y-yN
Dividend Yield %2.6PEG2.2ROE % (ttm)22.9Less Shares Outstanding y-yN
Payout Ratio %54.0Shares Outstanding M2,721ROIC % (ttm)31.6Gross Margin Increase y-yN

Gurus Latest Trades with JNJ

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
Current Price Change from Average Comment Current Shares

JNJ is held by these investors:

JNJ: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Stoffels PaulusExec VP, Chief Scientific Off 2017-02-15Sell22,000$117.293.76view
Ullmann Michael HExec VP, General Counsel 2017-02-01Sell21,735$112.887.81view
PRINCE CHARLESDirector 2016-10-21Buy875$114.116.65view
Caruso Dominic JExec VP, Finance; CFO 2016-07-26Sell41,146$125.01-2.65view
Kapusta Ronald AController, CAO 2016-07-22Sell2,935$125.01-2.65view
Pruden Gary JExec VP, WW Chair, Med Devices 2016-06-07Sell9,735$116.034.89view
Kapusta Ronald AController, CAO 2016-06-07Sell3,000$115.795.1view
Kapusta Ronald AController, CAO 2016-05-10Sell3,957$114.776.04view
Stoffels PaulusChief Scientific Officer 2016-02-17Sell125,000$102.4318.81view
Fasolo PeterVP, Global Human Resources 2016-02-03Sell151,385$104.1216.88view

Press Releases about JNJ :

Quarterly/Annual Reports about JNJ:

    News about JNJ:

    Articles On GuruFocus.com
    3 Dividend Stocks for 2017 Feb 21 2017 
    Under the Microscope: Gilead's Recent Dividend Increase Feb 15 2017 
    4 Companies Affected by Strength of the US Dollar Feb 13 2017 
    4 Companies That Will Benefit From Trump’s Repatriation Tax Reform Feb 13 2017 
    3 Dividend Stocks for 2017 Feb 13 2017 
    GuruFocus Interview: Orbimed Guru Sam Isaly on Investing in New Era of Healthcare Feb 15 2017 
    Beaten-Down Valuation and a 3% Dividend Yield Feb 07 2017 
    Merck: Analyzing 2016 Performance and Outlook for 2017 Feb 04 2017 
    4 Best Stocks for Value Investors This Week Jan 29 2017 
    Why Shareholders Care About Dividends Jan 27 2017 

    More From Other Websites
    Dow logs 10th straight record, but Nasdaq stumbles a second day Feb 23 2017
    Johnson & Johnson, Pfizer Lead DJIA Higher on Thursday Feb 23 2017
    United Therapeutics feeling squeeze from increased pulmonary hypertension competition Feb 23 2017
    8 Dow Dividend Stocks You Can Buy and Hold Forever Feb 23 2017
    [$$] Fusion Pharmaceuticals Raises $25 Million for Targeted Cancer Therapies Feb 23 2017
    Cramer: Buyers for Bristol-Myers Are Few and Far Between Feb 22 2017
    Genmab and J&J's cancer drug set for blockbuster sales this year Feb 22 2017
    Genmab and J&J's cancer drug set for blockbuster sales this year Feb 22 2017
    Genmab's Darzalex could achieve peak annual sales of $9 billion - CEO Feb 22 2017
    Genmab's Darzalex could achieve peak annual sales of $9 bln -CEO Feb 22 2017
    10 Companies With The Best Corporate Reputations Feb 22 2017
    3 Dividend Stocks for 2017 Feb 21 2017
    Bristol-Myers Buys Back Shares, Shuffles Board Feb 21 2017
    Torax Medical agrees to sell to Johnson & Johnson subsidiary Feb 21 2017
    5 Safe Dividend Stocks to Buy for Retirement Feb 21 2017
    The Zacks Analyst Blog Highlights: Merck, Valeant Pharmaceuticals International, Allergan,... Feb 21 2017
    Any Dip In Stocks Will Be A Gift To Buy Feb 19 2017
    The Natural Food Craze Is Now Sweeping Into Personal Care Products Feb 19 2017

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)